SBIR/STTR Research Award

Conductance to Measure Cardiac Mechanics

Award identifier cc85ae0e42d1d74fa93a776c53aff2f7af3d69bb1d8c038360f6f218449df390Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$139,234

Program and phase

STTR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MILLAR INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
JHTFBP2Y23Q7
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Applicant's Description Verbatim): The application of left ventricular pressure-volume relationships to transgenic mice to precisely measure contractility is not widely available. The long-term goal of this grant is to quantify left ventricular function in the intact mouse. Measurement of electrical conductance offers a method to generate an instantaneous left ventricular volume signal. The presently available instantaneous conductance output is a combination of blood and left ventricular muscle signals, but the blood volume (only) is desired. The problem can be solved by using two simultaneous frequencies, since myocardial resistivity varies with frequency while blood resistivity does not. The work will demonstrate that the dual frequency conductance system is superior to the standard single frequency system. A combination of experimental studies and numerical models will be used to calibrate the blood volume calculation when extracted from the combined blood and muscle signal. Finally, advances in instrumentation are proposed to move the dual frequency system to a closed-chest mouse preparation to enhance commercial interest. By removing the instantaneous myocardial contribution to the volume signal obtained during transient occlusion of the inferior vena cava, absolute measures of left ventricular contractility would be available. This would broaden the hemodynamic profile available from the intact murine left ventricle due to the wealth of information provided by pressure-volume analysis. PROPOSED COMMERCIAL APPLICATION: A dual frequency conductance system would allow scientists to precisely measure the complex phenotype of transgenic murine models of cardiovascular disease, such as congestive failure. Quantitation of left ventricular function would also allow the pharmaceutical industry to perform rapid screenting of new durgs in transgenic mice. The timing for these studies to understand the phenotype of selected genotypes is ideal as the Human Genome Project nears completion; and since humans and mice share a subset of highly conserved genes related to cardiovascular function.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

6 SBIR/STTR records share this UEI (2001–2016). Reported award amounts total $1,470,275. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.